A recent meta-analysis from 22 RCTs involving a total of 11,402 subjects showed that fibrate administration decreased fasting plasma glucose (−5 mg/dL), insulin levels (−0.56 μIU/mL), and insulin resistance (HOMA-IR: −1.09), but not HbA1C. The gene discussed is INS; the disease is Insulin resistance.